Almotriptan
AXERT^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Almotriptan
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

Indications and Usage

Almotriptan is a 5HT1B/1D receptor agonist (triptan) indicated for:

Acute treatment of migraine attacks in adults with a history of migraine with or without aura
Acute treatment of migraine headache pain in adolescents age 12 to 17 years with a history of migraine with or without aura, and who have migraine attacks usually lasting 4 hours or more

Use only after a clear diagnosis of migraine has been established
In adolescents age 12 to 17 years, efficacy of Almotriptan on migraine-associated symptoms was not established
Not intended for the prophylactic therapy of migraine
Not indicated for the treatment of cluster headache